NEOGLYATE

NEOGLYATE

neostigmine

Manufacturer:

Zydus (G.Rem)
Basic Prescribing Info
Contents
NEOGLYATE inj: neostigmine 2.5 mg, glycopyrrolate 0.5 mg.
CIMS Class
Neuromuscular Disorder Drugs
ATC Classification
N07AA51 - neostigmine, combinations ; Belongs to the class of anticholinesterase. Used as parasympathomimetics.
Presentation/Packing
Form
NEOGLYATE inj
Packing/Price
5ml (40 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in